A detailed history of Signaturefd, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Signaturefd, LLC holds 602 shares of MNKD stock, worth $3,666. This represents 0.0% of its overall portfolio holdings.

Number of Shares
602
Previous 602 -0.0%
Holding current value
$3,666
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$3.25 - $5.27 $8,427 - $13,665
-2,593 Reduced 81.16%
602 $2,000
Q2 2023

Aug 01, 2023

BUY
$3.72 - $4.79 $9,645 - $12,420
2,593 Added 430.73%
3,195 $13,000
Q1 2023

Apr 28, 2023

SELL
$3.95 - $5.63 $3,389 - $4,830
-858 Reduced 58.77%
602 $2,000
Q4 2022

Jan 27, 2023

SELL
$3.02 - $5.37 $2,458 - $4,371
-814 Reduced 35.8%
1,460 $7,000
Q2 2022

Aug 10, 2022

BUY
$2.67 - $4.77 $2,285 - $4,083
856 Added 60.37%
2,274 $9,000
Q2 2020

Jul 30, 2020

BUY
$0.94 - $2.21 $1,332 - $3,133
1,418 New
1,418 $2,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.57B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.